1407 GMT - Reckitt Benckiser investors are likely to focus on 2025 outlook as nothing major happened since the last earnings, Barclays analysts say in a note. The U.K. consumer-goods company is expected to provide 2025 guidance of 3% to 5% organic sales growth for its core business, which excludes essential home and Mead Johnson, they say. However, Reckitt could also issue a conservative target given the limited visibility, and volatility due to flu and retailer inventory dynamics, the analysts add. They warn, however, that almost every global health and personal care products company warned of an unusually weak 1Q, meaning the health segment could face pressures. Reckitt reports its 2024 results on Thursday. Shares are up 0.3% at 52.54 pounds. (michael.susin@wsj.com)
(END) Dow Jones Newswires
March 03, 2025 09:08 ET (14:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。